Neonatal (Preterm) infant care forms a significant part of the pediatric healthcare market in the U.S. as Neonatal (Preterm) births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are Neonatal (Preterm), and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking. Neonatal (Preterm) infant care products (equipment, drugs, and formulae) can thus be life-critical as they provide the respiratory, nutritional, and thermal support necessary for the survival of pre-term babies. The vital role of these products in Neonatal (Preterm) infant care thus forms the major factor driving market growth.
Market Estimates and Forecasts In addition to market data on the submarkets of the U.S. Neonatal (Preterm) infant care market, each section of the report will identify and analyze the market trends, opportunities, and the factors driving or inhibiting market growth. The report will also draw a competitive landscape, in which it will profile the top 35 market players. The report categorizes the U.S. Neonatal (Preterm) Infant Care market as follows:
Neonatal (Preterm) Infant Care Equipment (Diagnosis, therapy, and monitoring)
Neonatal (Preterm) Infant Formula (For use in hospitals, after discharge, iron fortified cow’s milk formulas, hydrolyzed whey based formulas, casein hydrolysate formulas, amino acid formulas)
Neonatal (Preterm) Infant Care Services Market (Diagnosis, therapy, and monitoring)
What makes our reports unique?
We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
Key questions answered
Which are the high-growth segments/cash cows and how is the market segmented in terms of devices, infant formula, drugs, services?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and analysis The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
TABLE OF CONTENTS
1 INTRODUCTION 29 1.1 KEY TAKE AWAYS 29 1.2 REPORT DESCRIPTION 29 1.3 MARKET ESTIMATES AND FORECASTS 29 1.4 STAKEHOLDERS 30 1.5 RESEARCH METHODOLOGY 30
2 SUMMARY 31
3 MARKET OVERVIEW 32 3.1 SOCIOECONOMIC IMPACT & COST ANALYSIS 34 3.2 DRIVERS 36 3.2.1 INCREASING INCIDENCE OF Neonatal (Preterm) BIRTHS 36 3.2.1.1 Inappropriate maternal age 37 3.2.1.2 Induced fertility treatments 38 3.2.1.3 Genetic predisposition 38 3.2.1.4 Lack of awareness and inadequate prenatal care 38 3.2.1.5 Obesity, diabetes, smoking 38 3.2.2 AVAILABILITY OF LOW-COST EQUIPMENT 39 3.2.3 GOVERNMENT INITIATIVES 39 3.3 RESTRAINTS & OPPORTUNITIES 40 3.3.1 HIGH ENTRY BARRIERS 40 3.3.2 NOVEL TRENDS IN INFANT FORMULAE 40 3.3.3 TECHNOLOGY DEVELOPMENTS 40 3.4 NOVEL APPROACHES TO Neonatal (Preterm) INFANT CARE 41 3.4.1 DEVELOPMENTAL CARE 41 3.4.2 NEONATAL INFORMATION SYSTEMS 42 3.5 KEY FINDINGS 43
8 PATENT ANALYSIS 123 8.1 PATENT ANALYSIS BY ASSIGNEE 123 8.2 PATENT ANALYSIS BY PRODUCTS 124 8.3 PATENT ANALYSIS BY EQUIPMENT 125
9 COMPANY PROFILES 128 9.1 ABBOTT NUTRITION 128 9.2 ANALOGIC CORP 130 9.3 ATOM MEDICAL INTERNATIONAL CORP. 131 9.4 ARJOHUNTLEIGH 132 9.5 CAREFUSION INC 133 9.6 CAS MEDICAL SYSTEMS INC 134 9.7 CHILDREN'S HOSPITAL OF PHILADELPHIA 136 9.8 CHILDREN'S NATIONAL MEDICAL CENTER 137 9.9 CLINICAL INNOVATIONS 138 9.10 COVIDIEN LTD. 140 9.11 CRITICARE SYSTEMS, INC. 141 9.12 DRAEGERWERK AG & CO. KGAA 142 9.13 EDAN INSTRUMENTS, INC 144 9.14 FISHER & PAYKEL HEALTHCARE CORP. 145 9.15 FUKUDA DENSHI CO. LTD. 146 9.16 GE HEALTHCARE 147 9.17 HAMILTON MEDICAL AG 149 9.18 KCBIOMEDIX, INC 150 9.19 MASIMO CORP. 151 9.20 MEAD JOHNSON NUTRITION CO 153 9.21 MEDELA INC. 155 9.22 MEDIX I.C.S.A 156 9.23 NATUS MEDICAL INC. 157 9.24 NESTLE NUTRITION 159 9.25 NEWYORK-PRESBYTERIAN MORGAN STANLEY CHILDREN'S HOSPITAL 160 9.26 NIHON KOHDEN CORP. 161 9.27 NONIN MEDICAL INC. 162 9.28 ORIDION SYSTEMS LTD 163 9.29 PEDIATRIX MEDICAL GROUP 165 9.30 PHOENIX MEDICAL SYSTEMS PVT LTD 167 9.31 PHILIPS RESPIRONICS INC 169 9.32 SPACELABS MEDICAL, INC 171 9.33 UTAH MEDICAL PRODUCTS, INC. 172 9.34 WELCH ALLYN INC. 173 9.35 WYETH NUTRITION CORP 175
APPENDIX 176 PATENTS 176
LIST OF TABLES
SUMMARY TABLE U.S. Neonatal (Preterm) INFANT CARE MARKET 2007 – 2014 ($MILLIONS) 31 TABLE 1 U.S. Neonatal (Preterm) INFANT CARE MARKET, BY SEGMENT 2007 – 2014 ($MILLIONS) 35 TABLE 2 U.S. Neonatal (Preterm) INFANT CARE SERVICES MARKET, 2007 – 2014 ($MILLIONS) 45 TABLE 3 U.S. Neonatal (Preterm) INFANT CARE EQUIPMENT MARKET, BY PRODUCTS 2007 – 2014 ($MILLIONS) 48 TABLE 4 U.S. Neonatal (Preterm) INFANT CARE THERAPY & MONITORING EQUIPMENT MARKET, 2007 – 2014 ($MILLIONS) 50 TABLE 5 PREMATURE DIAGNOSTIC DEVICES 59 TABLE 6 THERMAL CONTROL DEVICES 63 TABLE 7 MONITORING DEVICES 67 TABLE 8 DIAGNOSTIC EQUIPMENT 73 TABLE 9 U.S. Neonatal (Preterm) INFANT FORMULA MARKET, BY PRODUCTS 2007 – 2014 ($MILLIONS) 76 TABLE 10 AGREEMENTS AND COLLABORATIONS IN THE Neonatal (Preterm) INFANT CARE MARKET (2007-2009) 85 TABLE 11 NEW PRODUCT LAUNCHES IN THE Neonatal (Preterm) INFANT CARE MARKET (2007-2009) 89 TABLE 12 MERGERS AND ACQUISITIONS IN THE Neonatal (Preterm) INFANT CARE MARKET (2006-2009) 93 TABLE 13 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - MISSISSIPPI 98 TABLE 14 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - ALABAMA 100 TABLE 15 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - DISTRICT OF COLUMBIA 101 TABLE 16 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - LOUISIANA 103 TABLE 17 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - KENTUCKY 104 TABLE 18 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - SOUTH CAROLINA 105 TABLE 19 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - TENNESSEE 106 TABLE 20 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - NEVADA 107 TABLE 21 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - NEW MEXICO 109 TABLE 22 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - GEORGIA 110 TABLE 23 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - WEST VIRGINIA 111 TABLE 24 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - OKLAHOMA 112 TABLE 25 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - FLORIDA 113 TABLE 26 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - TEXAS 115 TABLE 27 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - ARKANSAS 116 TABLE 28 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - CALIFORNIA 117 TABLE 29 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - NEW YORK 118 TABLE 30 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - OHIO 119 TABLE 31 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - ILLINOIS 120 TABLE 32 Neonatal (Preterm) BIRTH RATE IN ETHNICITIES - PENNSYLVANIA 121
LIST OF FIGURES
FIGURE 1 CURRENT Neonatal (Preterm) BIRTH RATE IN THE U.S 32 FIGURE 2 SOCIOECONOMIC COSTS 34 FIGURE 3 INCREASING RATES Neonatal (Preterm) BIRTHS IN THE U.S. 36 FIGURE 4 PROMINENT RISK FACTORS CAUSING Neonatal (Preterm) BIRTHS 37 FIGURE 5 DEVELOPMENTAL CARE 41 FIGURE 6 UTILIZATION RATES OF RESPIRATORY ASSISTANCE DEVICES IN Neonatal (Preterm) INFANT CARE 55 FIGURE 7 TECHNOLOGY TRENDS IN THE RESPIRATORY ASSISTANCE DEVICES MARKET 56 FIGURE 8 PERCENT UTILIZATION RATES OF THERMAL CONTROL EQUIPMENT 61 FIGURE 9 TECHNOLOGY TRENDS IN THE MONITORING DEVICES MARKET 64 FIGURE 10 TECHNOLOGY DEVELOPMENT IN THE DIAGNOSTIC EQUIPMENT MARKET 70 FIGURE 11 UTILIZATION RATES OF DIAGNOSTIC EQUIPMENT IN Neonatal (Preterm) INFANT CARE 71 FIGURE 12 PRODUCT DEVELOPMENT IN THENeonatal (Preterm) INFANT CARE MARKET 80 FIGURE 13 PRODUCT DEVELOPMENTS IN MEDICAL DEVICES 82 FIGURE 14 NEW PRODUCT LAUNCHES 83 FIGURE 15 AGREEMENTS AND COLLABORATIONS 84 FIGURE 16 Neonatal (Preterm) BIRTH RATES, BY STATES 96 FIGURE 17 PATENT ANALYSIS, BY ASSIGNEE (2000 – 2009) 123 FIGURE 18 124PATENTS ANALYSIS, BY PRODUCTS (2000 – 2009) 124 FIGURE 19 PATENTS ANALYSIS, BY EQUIPMENT (2000 – 2009) 125 FIGURE 20 PATENT ANALYSIS, BY THERAPY & MONITORING EQUIPMENT (2000 – 2009) 126
U.S Neonatal (Preterm) Infant Care Market
Neonatal (Preterm) births are one of the leading causes of infant mortality in the U.S., and thus Neonatal (Preterm) infant care forms a significant part of the U.S. pediatric healthcare market. One in every eight births in the U.S. are Neonatal (Preterm), and such births are on the rise due to the factors such as induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking. Neonatal (Preterm) infant care products can be life-critical as they provide essential respiratory and nutritional support for pre-term babies.
The equipment segment of overall Neonatal (Preterm) infant car market covers respiratory assistance devices, delivery systems, thermal control equipment, monitoring and diagnostic devices, and bili lights. This market is relatively mature with numerous players offering both basic and sophisticated equipment at affordable costs. However, the sales of replacement units generate the most market revenues.
While developments such as the use of nanotechnology in is driving the growth of the Neonatal (Preterm) infant care equipment market, the Neonatal (Preterm) infant formula market is also witnessing innovations with introduction of novel ingredients such as probiotics, which also prevent infections while promoting growth and development in Neonatal (Preterm) infants.
The U.S Neonatal (Preterm) infant care market is expected to grow from $21.2 billion in 2009 to $25.4 billion in 2014 at a CAGR of 3.7% from 2009 to 2014. Market participants such as the manufacturers of Neonatal (Preterm) infant care equipment, formulae, and pharmaceuticals are forming business consolidations and are also opting for new product launches as a part of their competitive strategy to enhance their market position.
Please fill in the form below to receive a sample copy of the report.
Custom Research
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.